Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Survey on Interdisciplinary Management of Cardiotoxicity in Outpatient Sett
Author(s): Silvio Quick , Lorena Payo-Anez , Clara Marx Casimiro de Almeida , et al Added: 12 months ago

Guidelines & Statements

Imaging & Diagnostics
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 5 months ago

CV Disease in Special Populations

Heart Failure
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

 Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more
Frailty and Cardio-oncology
Author(s): Erkihun Amsalu , Tan Van Nguyen , Harry Klimis , et al Added: 2 months ago

CV Disease in Special Populations

Heart Failure
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 10 months ago

CV Disease in Special Populations

Heart Failure
Ian Paterson
Job title: Professor
Dr Ian Paterson is a Professor of Medicine in the Division of Cardiology at the University of Alberta. He completed his Cardiology training and an Echocardiography Fellowship at the McGill University, followed by a Cardiovascular MRI Fellowship at the National Institutes of Health. Dr Paterson is also the Academic and Research Director of Cardiovascular Magnetic Resonance at the University of… View more
Aarti Asnani
Job title: MD
Dr Asnani is Associate Director and an attending physician in the Cardio-Oncology Program at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts and is an active researcher in the field. She joined BIDMC in 2017 and prior to this worked at the Massachusetts General Hospital. She earned her medical degree at the Duke School of Medicine, Durham, North Carolina in 2008, one of the… View more
Ibrutinib, Venetoclax and Adverse Cardiovascular Events
Author(s): Roberta Esposito , Pierantonio Menna , Emanuela Salvatorelli , et al Added: 4 months ago

CV Disease in Special Populations

Prevention & Chronic Conditions
Rebecca Dobson
Research Area(s) / Expertise: Job title: Consultant Cardiologist
Dr Rebecca Dobson is a Consultant Cardiologist at theLiverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool Heart & Chest Hospital, in Liverpool, UK. She has a special interest in imaging and cardio-oncology. Dr Dobson's research interests include cardio-oncology, cardiac imaging and advanced echocardiography, including chemotherapy-induced left ventricular… View more